Acadian Asset Management »

Rapt Therapeutics shares owned by Acadian Asset Management

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Acadian Asset Management from 13F filings

Historical chart of Acadian Asset Management investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Acadian Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Acadian Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $97k 11k 8.89

More positions owned by Acadian Asset Management

NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Stellantis SHS (STLA)
Check Point Software Tech Ord (CHKP)
Logitech Intl S A SHS (LOGI)
Apple (AAPL)
Spotify Technology S A SHS (SPOT)
Meta Platforms Cl A (META)
McKesson Corporation (MCK)
Cardinal Health (CAH)
Reliance Steel & Aluminum (RS)
Marathon Petroleum Corp (MPC)
Booking Holdings (BKNG)

View all positions for Acadian Asset Management

Top funds holding Rapt Therapeutics

FMR
Column Group
Vanguard Group
BlackRock
T. Rowe Price Associates
Morgan Stanley
Kingdon Capital Management
Perceptive Advisors
Geode Capital Management
Redmile Group
State Street Corporation
Euclidean Capital
Affinity Asset Advisors
Dimensional Fund Advisors
Alphabet

View all funds holding Rapt Therapeutics